BRIDGEWATER, N.J.--(BUSINESS WIRE)--Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX) (“Amneal” or the “Company”) today announced that the U.S. Food and Drug Administration (FDA) has approved ...
WOODCLIFF LAKE, N.J. & NEW YORK--(BUSINESS WIRE)-- Eisai Inc. and Pfizer Inc [NYSE: PFE] announced today that the U.S. Food and Drug Administration (FDA) approved a new once-daily, higher-dose Aricept ...
July 27, 2010 — The US Food and Drug Administration (FDA) has approved donepezil HCl 23-mg tablets (Aricept; Eisai, Inc and Pfizer, Inc) for the once-daily treatment of moderate to severe Alzheimer's ...
Answer this question. People with dementia usually have lower levels of this chemical, which is important for the processes of … 5. Those with a hard coating and capsules of any kind are best ...
Aricept’s cost may depend on factors such as your dosage, insurance coverage, and the pharmacy you use. In general, your out-of-pocket costs may be higher if you’re prescribed a higher dosage or if ...
Honolulu, Hawaii (April 4, 2003) -- The leading Alzheimer's treatment, ARICEPT® (donepezil HCl tablets), may also benefit patients with vascular dementia (VaD), according to a study analysis presented ...
April 2, 2012 — Approval for the new 23-mg dose of the Alzheimer's disease (AD) drug donepezil (Aricept, Eisai) "breached the FDA's own regulatory standard" and has led to "incomplete and distorted ...
SAN DIEGO — A once-weekly dose of transdermal donepezil proved a safe and effective equivalent to a daily dose of oral donepezil for Alzheimer’s-related dementia, per a presenter at the Alzheimer’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback